For self-ventilating patients, Aerogen can effectively
deliver aerosol medication required for symptom
control during respiratory exacerbations1,2,*3,†4
Product Description
- Significantly fewer treatments and significantly less time required to achieve symptom control
- ~30% relative reduction in hospital admission rates
- 85% of patients achieving symptom control with one 2.5 mg salbutamol dose
- 37-minute reduction in emergency department median length of stay
- 6x more medication delivered to the lungs during self-ventilation versus a jet nebulizer
- Significantly less medication left in the cup versus other nebulizers
Contact our sales team
If you are interested in this product, need our help, or are experiencing technical difficulties, please do not hesitate to contact us by completing the form below.
"*" indicates required fields
